TN2011000134A1 - Polytherapie destinee a traiter une infection par le vhc - Google Patents

Polytherapie destinee a traiter une infection par le vhc

Info

Publication number
TN2011000134A1
TN2011000134A1 TN2011000134A TN2011000134A TN2011000134A1 TN 2011000134 A1 TN2011000134 A1 TN 2011000134A1 TN 2011000134 A TN2011000134 A TN 2011000134A TN 2011000134 A TN2011000134 A TN 2011000134A TN 2011000134 A1 TN2011000134 A1 TN 2011000134A1
Authority
TN
Tunisia
Prior art keywords
polytherapie
destinee
vhc
une infection
infection par
Prior art date
Application number
TN2011000134A
Other languages
French (fr)
Inventor
Gerhard Gustav Steinmann
Jerry O Stern
David Huang
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2009/056771 external-priority patent/WO2010033443A1/en
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of TN2011000134A1 publication Critical patent/TN2011000134A1/en

Links

Abstract

The present invention relates to therapeutic combinations comprising (a) Compound (1), or a pharmaceutically acceptable salt thereof, as herein described, (b) an interferon alfa and (c) ribavirin. Compound (1) is a selective and potent inhibitor of the HCV NS3 serine protease. The present invention also relates to methods of using such therapeutic combinations for treating HCV infection or alleviating one or more symptoms thereof in a patient.
TN2011000134A 2009-09-14 2011-03-15 Polytherapie destinee a traiter une infection par le vhc TN2011000134A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2009/056771 WO2010033443A1 (en) 2008-09-17 2009-09-14 Combination of hcv ns3 protease inhibitor with interferon and ribavirin

Publications (1)

Publication Number Publication Date
TN2011000134A1 true TN2011000134A1 (en) 2012-09-05

Family

ID=55024422

Family Applications (1)

Application Number Title Priority Date Filing Date
TN2011000134A TN2011000134A1 (en) 2009-09-14 2011-03-15 Polytherapie destinee a traiter une infection par le vhc

Country Status (1)

Country Link
TN (1) TN2011000134A1 (en)

Similar Documents

Publication Publication Date Title
MY152824A (en) Combination of hcv ns3 protease inhibitor with interferon and ribavirin.
MX2009009174A (en) Inhibitors of serine proteases for the treatment of hcv infections.
NZ599284A (en) Combinations of a specific hcv ns5a inhibitor and an hcv ns3 protease inhibitor
MX2009009176A (en) Inhibitors of serine proteases.
ES2572329A2 (en) Combination of at least two antiviral agents of direct action and ribavirina but not interfered, for use in the vhc treatment (Machine-translation by Google Translate, not legally binding)
MY148123A (en) Inhibitors of serine proteases, particularly hcv ns3-ns4a protease
WO2007016476A3 (en) Hepatitis c serine protease inhibitors and uses therefor
JO2593B1 (en) HCV NS3 Protease Inhibitors
TW200510391A (en) Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
MX2009004556A (en) Hcv ns3 protease inhibitors.
SG159385A1 (en) Inhibitors of serine proteases, particularly hepatitis c virus ns3 - ns4 protease
MX2010006210A (en) Fluorinated tripeptide hcv serine protease inhibitors.
WO2005077969A3 (en) Inhibitors of serine proteases, particularly hcv ns3-ns4a protease
TNSN06071A1 (en) Use of modified cyclosporins for the treatment of hcv disorders
EA200900969A1 (en) MACROCYCLIC INHIBITORS OF HEPATITIS C PROTEASE
MX2013003060A (en) Combination therapy for treating hcv infection.
EA201200650A1 (en) COMBINED TREATMENTS OF HEPATITIS C VIRUS, INCLUDING BI201335, INTERFERON-ALPHA AND RIBAVIRIN COURSES
WO2010034105A8 (en) Hepatitis c inhibitor compounds
MX2010008108A (en) Heteroaryl-containing tripeptide hcv serine protease inhibitors.
WO2008046860A3 (en) Bioavailable combinations for hcv treatment
MX2013004906A (en) Novel specific hcv ns3 protease inhibitors.
UA90909C2 (en) Hcv ns3 protease inhibitors
WO2009067225A3 (en) Boceprevir derivatives for the treatment of hcv infections
MX2013003551A (en) Solid state forms of a potent hcv inhibitor.
TN2011000134A1 (en) Polytherapie destinee a traiter une infection par le vhc